Abrogation of the tumor promoting effect of allogeneic blood transfusion by polyadenylic-polyuridylic acid (poly A-poly U)
- PMID: 3677125
- PMCID: PMC11038455
- DOI: 10.1007/BF00199153
Abrogation of the tumor promoting effect of allogeneic blood transfusion by polyadenylic-polyuridylic acid (poly A-poly U)
Abstract
Studies from several centers have shown an immunosuppressive effect of surgical procedures, whilst others have shown blood transfusion in association with cancer surgery to have an adverse effect on ultimate prognosis. We have previously demonstrated enhanced growth of tumor metastases, in rats following allogeneic blood transfusion and surgery. Polyadenylic-polyuridylic acid (poly A-poly U) has been reported to stimulate immune responses. In this report, we have investigated the effectiveness of poly A-poly U as an adjuvant to blood transfusion and surgical procedures in BN rats bearing artificial lung metastases. Significantly reduced tumor growth was observed, following poly A-poly U adjuvant treatment. These results lead to serious contemplation of the use of this drug as adjuvant therapy in blood transfused and surgically treated patients.
Similar articles
-
[Adjuvant immunotherapy with polyadenylic-polyuridylic acid (Poly A.Poly U) in operable cancer of the breast. Recent results of a controlled therapeutic trial].Chirurgie. 1984;110(4):418-24. Chirurgie. 1984. PMID: 6389040 Clinical Trial. French. No abstract available.
-
Enhanced growth of artificial tumor metastases following blood transfusion: the effect of erythrocytes, leukocytes and plasma transfusion.Eur J Cancer Clin Oncol. 1987 Oct;23(10):1537-40. doi: 10.1016/0277-5379(87)90097-6. Eur J Cancer Clin Oncol. 1987. PMID: 3678317
-
Adjuvant effect of polyadenylic.polyuridylic acid on antibody production of recombinant hepatitis B surface antigen in mice.Int J Immunopharmacol. 1995 Jun;17(6):513-6. doi: 10.1016/0192-0561(95)00031-v. Int J Immunopharmacol. 1995. PMID: 7499028
-
Perioperative blood transfusions and survival in osteosarcoma.Cancer Treat Res. 1993;62:25-8. doi: 10.1007/978-1-4615-3518-8_4. Cancer Treat Res. 1993. PMID: 8096741 Review. No abstract available.
-
[Therapeutic trial of Poly(A).Poly(U) adjuvant immunotherapy in operable cancer of the breast. Long-term results].Chirurgie. 1988;114(6):516-23. Chirurgie. 1988. PMID: 3067998 Review. French. No abstract available.
References
-
- Bijma AM, Baan CC, Kort WJ, Marquet RL, Westbroek DL. Effect of poly A-poly U on NK cell activity, interferon production and development of metastases in rats. Eur Surg Res. 1985;17:94–95.
-
- Bonadonna G, Valagussa P. Dose response effect of adjuvant chemotherapy in breast cancer. New Engl J Med. 1981;304:10–15. - PubMed
-
- Braun M, Nakano M. Antibody formation: stimulation by poly A-poly C. Science. 1979;157:819. - PubMed
-
- Braun W, Ishizuka M, Yajima Y, Webb D, Winchurch . Spectrum and mode of action of poly A-poly U in the stimulation of immune responses. New York: Springer; 1971. pp. 139–156.
-
- Burrows L, Tartter P. Effect of blood transfusions on colonic malignancy recurrence rate. Lancet. 1982;2:662. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical